Loading clinical trials...
Loading clinical trials...
The Effects of Ferric Derisomaltose Administered Before Hospital Discharge in Stabilised Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life: a Randomised, Parallel-group, Double-blind, Placebo Controlled Trial (COREVIVE-HFrEF)
Conditions
Interventions
Ferric derisomaltose
Placebo
Locations
1
China
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
Start Date
August 1, 2023
Primary Completion Date
August 1, 2024
Completion Date
August 1, 2025
Last Updated
August 15, 2023
NCT07484009
NCT06884280
NCT06967441
NCT07057466
NCT05392764
NCT07321509
Lead Sponsor
China-Japan Friendship Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions